Typicality: | 0.414 |
Saliency: | 0.384 |
on the basis of application | 32 | other |
by application | 6 | other |
further | 4 | degree |
market → be segmented into → drug discovery | 34 |
market → be segmented into → drug development | 10 |
market → be segmented as → drug discovery | 5 |
negative | neutral | positive |
0.053 | 0.882 | 0.065 |
Raw frequency | 49 |
Normalized frequency | 0.384 |
Modifier score | 0.500 |
Perplexity | 198.964 |